208 related articles for article (PubMed ID: 21169070)
1. DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables.
Kamalakaran S; Varadan V; Giercksky Russnes HE; Levy D; Kendall J; Janevski A; Riggs M; Banerjee N; Synnestvedt M; Schlichting E; Kåresen R; Shama Prasada K; Rotti H; Rao R; Rao L; Eric Tang MH; Satyamoorthy K; Lucito R; Wigler M; Dimitrova N; Naume B; Borresen-Dale AL; Hicks JB
Mol Oncol; 2011 Feb; 5(1):77-92. PubMed ID: 21169070
[TBL] [Abstract][Full Text] [Related]
2. Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes.
Park SY; Kwon HJ; Choi Y; Lee HE; Kim SW; Kim JH; Kim IA; Jung N; Cho NY; Kang GH
Mod Pathol; 2012 Feb; 25(2):185-96. PubMed ID: 22037257
[TBL] [Abstract][Full Text] [Related]
3. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R
Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846
[TBL] [Abstract][Full Text] [Related]
4. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
[TBL] [Abstract][Full Text] [Related]
5. Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns.
Holm K; Hegardt C; Staaf J; Vallon-Christersson J; Jönsson G; Olsson H; Borg A; Ringnér M
Breast Cancer Res; 2010; 12(3):R36. PubMed ID: 20565864
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival.
Conway K; Edmiston SN; May R; Kuan PF; Chu H; Bryant C; Tse CK; Swift-Scanlan T; Geradts J; Troester MA; Millikan RC
Breast Cancer Res; 2014 Oct; 16(5):450. PubMed ID: 25287138
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence.
Fackler MJ; Umbricht CB; Williams D; Argani P; Cruz LA; Merino VF; Teo WW; Zhang Z; Huang P; Visvananthan K; Marks J; Ethier S; Gray JW; Wolff AC; Cope LM; Sukumar S
Cancer Res; 2011 Oct; 71(19):6195-207. PubMed ID: 21825015
[TBL] [Abstract][Full Text] [Related]
8. DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status.
Flanagan JM; Cocciardi S; Waddell N; Johnstone CN; Marsh A; Henderson S; Simpson P; da Silva L; ; Khanna K; Lakhani S; Boshoff C; Chenevix-Trench G
Am J Hum Genet; 2010 Mar; 86(3):420-33. PubMed ID: 20206335
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation epigenotypes in breast cancer molecular subtypes.
Bediaga NG; Acha-Sagredo A; Guerra I; Viguri A; Albaina C; Ruiz Diaz I; Rezola R; Alberdi MJ; Dopazo J; Montaner D; Renobales M; Fernández AF; Field JK; Fraga MF; Liloglou T; de Pancorbo MM
Breast Cancer Res; 2010; 12(5):R77. PubMed ID: 20920229
[TBL] [Abstract][Full Text] [Related]
10. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.
Kao J; Salari K; Bocanegra M; Choi YL; Girard L; Gandhi J; Kwei KA; Hernandez-Boussard T; Wang P; Gazdar AF; Minna JD; Pollack JR
PLoS One; 2009 Jul; 4(7):e6146. PubMed ID: 19582160
[TBL] [Abstract][Full Text] [Related]
11. Association of poor prognosis subtypes of breast cancer with estrogen receptor alpha methylation in Iranian women.
Izadi P; Mehrdad N; Foruzandeh F; Reza NM
Asian Pac J Cancer Prev; 2012; 13(8):4113-7. PubMed ID: 23098526
[TBL] [Abstract][Full Text] [Related]
12. Identification of methylation sites and signature genes with prognostic value for luminal breast cancer.
Xiao B; Chen L; Ke Y; Hang J; Cao L; Zhang R; Zhang W; Liao Y; Gao Y; Chen J; Li L; Hao W; Sun Z; Li L
BMC Cancer; 2018 Apr; 18(1):405. PubMed ID: 29642861
[TBL] [Abstract][Full Text] [Related]
13. A DNA methylation-based definition of biologically distinct breast cancer subtypes.
Stefansson OA; Moran S; Gomez A; Sayols S; Arribas-Jorba C; Sandoval J; Hilmarsdottir H; Olafsdottir E; Tryggvadottir L; Jonasson JG; Eyfjord J; Esteller M
Mol Oncol; 2015 Mar; 9(3):555-68. PubMed ID: 25468711
[TBL] [Abstract][Full Text] [Related]
14. Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter.
Poli E; Zhang J; Nwachukwu C; Zheng Y; Adedokun B; Olopade OI; Han YJ
PLoS One; 2015; 10(11):e0142224. PubMed ID: 26539832
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity.
Hill VK; Ricketts C; Bieche I; Vacher S; Gentle D; Lewis C; Maher ER; Latif F
Cancer Res; 2011 Apr; 71(8):2988-99. PubMed ID: 21363912
[TBL] [Abstract][Full Text] [Related]
16. Lowly methylated region analysis identifies EBF1 as a potential epigenetic modifier in breast cancer.
Fernandez-Jimenez N; Sklias A; Ecsedi S; Cahais V; Degli-Esposti D; Jay A; Ancey PB; Woo HD; Hernandez-Vargas H; Herceg Z
Epigenetics; 2017; 12(11):964-972. PubMed ID: 29099283
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
Mishra NK; Guda C
Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
[TBL] [Abstract][Full Text] [Related]
18. Vimentin DNA methylation predicts survival in breast cancer.
Ulirsch J; Fan C; Knafl G; Wu MJ; Coleman B; Perou CM; Swift-Scanlan T
Breast Cancer Res Treat; 2013 Jan; 137(2):383-96. PubMed ID: 23239149
[TBL] [Abstract][Full Text] [Related]
19. Gene expression and DNA methylation analyses suggest that immune process-related ADCY6 is a prognostic factor of luminal-like breast cancer.
Li W; Sang M; Hao X; Jia L; Wang Y; Shan B
J Cell Biochem; 2020 Jul; 121(7):3537-3546. PubMed ID: 31886586
[TBL] [Abstract][Full Text] [Related]
20. The ability to generate senescent progeny as a mechanism underlying breast cancer cell heterogeneity.
Mumcuoglu M; Bagislar S; Yuzugullu H; Alotaibi H; Senturk S; Telkoparan P; Gur-Dedeoglu B; Cingoz B; Bozkurt B; Tazebay UH; Yulug IG; Akcali KC; Ozturk M
PLoS One; 2010 Jun; 5(6):e11288. PubMed ID: 20585577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]